[Magnetic resonance imaging of the brain in multiple sclerosis]

V P Kharchenko1, E V Krivenko, N M Nikiforuk

  • 1Moscow Research Institute of Diagnosis and Surgery, Ministry of Health and Medical Industry of the Russian Federation.

Insights

Low-magnetic induction magnetic resonance imaging (MRI) effectively detects brain lesions in multiple sclerosis (MS). This study clarifies diagnostic signs and highlights MRI findings that may mimic MS, aiding differential diagnosis.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Context:

  • Demyelinating diseases of the central nervous system, particularly multiple sclerosis (MS), pose diagnostic challenges.
  • Magnetic resonance imaging (MRI) is a key tool for diagnosing MS.
  • The efficacy of low-magnetic induction MRI in MS diagnosis requires further investigation.

Purpose:

  • To assess the capability of low-magnetic induction MRI to detect focal brain changes in multiple sclerosis.
  • To clarify and classify the tomographic signs of MS using low-magnetic induction MRI.
  • To identify and summarize cases where MRI abnormalities can clinically mask MS, aiding differential diagnosis.

Summary:

  • Brain MRI was performed on 255 patients with multiple sclerosis using Russian low-magnetic induction tomographs ('Obraz' and 'Ellips').
  • The study confirmed that low-magnetic induction MRI can detect focal brain changes characteristic of MS.
  • A correlation was found between disease duration and the detection of focal brain lesions. Specific MRI findings that can mimic MS were identified and categorized to assist in differential diagnosis.

Impact:

  • Provides evidence for the utility of low-magnetic induction MRI in diagnosing multiple sclerosis, potentially increasing accessibility to advanced imaging.
  • Enhances the understanding of MS-related MRI findings and their classification.
  • Offers a valuable resource for clinicians in differentiating MS from other conditions presenting with similar MRI abnormalities.

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...